Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity

Neurofilament light chain (NfL) has been demonstrated to correlate with multiple sclerosis disease severity as well as treatment response. Nevertheless, additional serum biomarkers are still needed to better differentiate disease activity from disease progression. The aim of our study was to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayrignac, Xavier, Le Bars, Emmanuelle, Duflos, Claire, Hirtz, Christophe, Maleska Maceski, Aleksandra, Carra-Dallière, Clarisse, Charif, Mahmoud, Pinna, Frédéric, Prin, Pauline, Menjot de Champfleur, Nicolas, Deverdun, Jérémy, Kober, Tobias, Marechal, Bénédicte, Fartaria, Mario Joao, Corredor Jerez, Ricardo, Labauge, Pierre, Lehmann, Sylvain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331703/
https://www.ncbi.nlm.nih.gov/pubmed/32616916
http://dx.doi.org/10.1038/s41598-020-67934-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331703/
https://www.ncbi.nlm.nih.gov/pubmed/32616916
http://dx.doi.org/10.1038/s41598-020-67934-2

Ejemplares similares